$6.78
0.060.89%
Last update: Nov 9, 5:23 PM
Achieve Life Sciences Inc
ACHVNASDAQ
Achieve Life Sciences rose 52.4% from $4.45 to $6.78, ahead of the S&P 500's +10.5%. Its worst day was Mar 24 (−28.4%), and its low came Mar 27 at $2.65.
Nov 10, 2025 – Nov 9, 2026 · picked from earnings, analyst actions, headlines and the biggest daily moves
Achieve Life Sciences shares rose 15.6%, while the S&P 500 rose 0.9%.
+15.6% · S&P 500 +0.9%
EPS of $-0.28 missed the $-0.27 estimate on $0.00 revenue.
−28.4%, the year's worst day · S&P 500 −0.3%
Story events cover the past 12 months · Times ET
Achieve Life Sciences shares rose 35.5%, while the S&P 500 rose 0.2%.
+35.5%, the year's best day, on 14M shares, the year's heaviest volume · S&P 500 +0.2%
EPS of $-0.19 beat the $-0.30 estimate on $0.00 revenue.
+7.2% · S&P 500 −0.2%
EPS of $-0.80 missed the $-0.16 estimate on $0.00 revenue.
+1.5% · S&P 500 −0.3%
Achieve Life Sciences closed at its highest level of the year, 91.7% above where the year started.
+13.4% · S&P 500 +0.2%
Where it ended: a close of $6.78 on Nov 9, 2026. Up next: Q3 2026 earnings on Nov 24, 2026 (EPS est. $-0.19).
Nothing in the past 12 months.
All ACHV dividend historyReplay the year: the line draws itself and stops at each of the 6 moments with what happened and how the stock reacted.
Chart by ChartIQ. Events, ratings, quote and fundamentals from Benzinga APIs. Daily bars for ACHV and SPY from Benzinga historical bars. Not investment advice.
